Latest News on NHI

Financial News Based On Company


Advertisement
Advertisement

CEO D. Eric Mendelsohn buys 1,500 National Health Investors (NHI) shares at $60.53 each.

https://www.stocktitan.net/sec-filings/NHI/form-4-national-health-investors-inc-insider-trading-activity-84fa1cdc4f30.html
D. Eric Mendelsohn, CEO and President of National Health Investors Inc., purchased 1,500 shares of the company's common stock on November 17, 2026, at a price of $60.53 per share. This direct purchase increased his total direct holdings to 134,816 shares, with no Rule 10b5-1 plan reported. The transaction, filed as a Form 4, indicates a positive sentiment and high filing impact.

National Health Investors (NYSE:NHI) Stock: Insider D. Eric Mendelsohn Buys 1,500 Shares

https://www.marketbeat.com/instant-alerts/insider-national-health-investors-nyse-nhi-stock-insider-d-eric-mendelsohn-buys-1500-shares-2026-11-18/
National Health Investors (NYSE:NHI) CEO D. Eric Mendelsohn recently purchased 1,500 shares of the company's stock for $90,795, increasing his total holdings to 134,816 shares. The company also declared a quarterly dividend of $0.92 per share, resulting in an annualized dividend of $3.68 and a 6.1% yield. Analysts currently have a "Moderate Buy" consensus rating for NHI, with an average price target of $79.11.

NHI CEO D. Eric Mendelsohn buys $90,795 in company stock By Investing.com

https://ca.investing.com/news/stock-market-news/nhi-ceo-d-eric-mendelsohn-buys-90795-in-company-stock-93CH-4967076
D. Eric Mendelsohn, CEO of National Health Investors Inc. (NYSE:NHI), recently bought 1,500 shares of company stock for $90,795, with the stock trading near its 52-week low. This purchase comes as InvestingPro analysis suggests the stock is undervalued with a fair value of $78.85 and maintains a 6.27% dividend yield. The company also recently reported strong Q3 2026 EPS driven by a one-time gain, despite a revenue miss, and a downgrade by BofA Securities due to weaker SHOP execution.

Form 4 National Health Investors Inc: D. Eric Mendelsohn (Director, CEO and President) For: 17 November

https://ca.investing.com/news/stock-market-news/form-4-national-health-investors-inc-d-eric-mendelsohn-director-ceo-and-president-for-17-november-93CH-4967095
This article reports on a Form 4 filing for National Health Investors Inc., detailing a transaction involving D. Eric Mendelsohn, who serves as a Director, CEO, and President of the company. The filing is dated for November 17. The article provides the title of the filing and mentions the company's stock symbol NHI.

National Health Investors enters into indemnification agreements with directors

https://medicalbuyer.co.in/national-health-investors-enters-into-indemnification-agreements-with-directors/
National Health Investors, Inc. (NHI) has entered into indemnification agreements with its directors and certain officers, requiring the company to cover legal expenses and liabilities incurred by these individuals, unless they acted in bad faith or engaged in unlawful conduct. This move follows the company's strong Q3 2026 earnings, which significantly surpassed analyst expectations due to a major portfolio sale, although revenue fell short. In other news, BofA Securities downgraded NHI due to weaker SHOP execution and reduced fiscal 2026 guidance.
Advertisement

National Health Investors (NYSE:NHI) Stock Price Target Lowered at Wells Fargo & Company

https://www.marketbeat.com/instant-alerts/analyst-national-health-investors-nyse-nhi-stock-price-target-lowered-at-wells-fargo-company-2026-11-16/
Wells Fargo & Company has lowered its price target for National Health Investors (NYSE:NHI) from $68.00 to $65.00, maintaining an "equal weight" rating, which suggests a potential upside of 3.89%. Despite this, the stock holds a "Moderate Buy" consensus rating from MarketBeat.com with an average target of $79.11. The REIT recently surpassed Q3 earnings and revenue estimates, reporting $11.47 EPS against an expected $1.18 and $113.48 million in revenue compared to $68.53 million.

National Health Investors stock hits 52-week low at 63.31 USD By Investing.com

https://ca.investing.com/news/stock-market-news/national-health-investors-stock-hits-52week-low-at-6331-usd-93CH-4957253
National Health Investors (NHI) stock recently hit a 52-week low of $63.31, reflecting a 9.4% weekly decline and a 17.17% annual decline, despite appearing undervalued with a P/E of 4.54 and a 5.82% dividend yield. The company reported strong Q3 2026 EPS of $11.47, exceeding expectations due to a one-time gain from the sale of its NHC portfolio, though revenue missed forecasts. BofA Securities downgraded NHI to Underperform, citing weaker execution and reduced fiscal 2026 guidance.

National Health Investors stock hits 52-week low at 63.31 USD By Investing.com

https://www.investing.com/news/company-news/national-health-investors-stock-hits-52week-low-at-6331-usd-93CH-5025936
National Health Investors Inc. (NHI) stock recently hit a 52-week low of $63.31, marking a significant 9.4% decline in the past week and 17.17% over the last year. Despite this downturn, InvestingPro analysis suggests the healthcare REIT is undervalued, trading at a P/E of 4.54 and offering a 5.82% dividend yield. The company also reported strong Q3 2026 EPS due to a one-time gain, though revenue missed expectations and BofA Securities downgraded the stock due to operational concerns.

Form 8K National Health Investors Inc For: 13 November By Investing.com

https://ca.investing.com/news/stock-market-news/form-8k-national-health-investors-inc-for-13-november-93CH-4957940
National Health Investors Inc. (NHI) filed a Form 8K on November 13, 2026, which is a report used to announce significant events that shareholders should know about. The article itself serves as a brief notification of this filing, indicating that further details would be found within the Form 8K document. The stock symbol NHI is mentioned with a -2.48% change.

National Health downgraded by BofA Securities with a new price target

https://quantisnow.com/insight/national-health-downgraded-by-bofa-securities-with-a-new-price-6789384
BofA Securities has downgraded National Health (NHI) from Buy to Underperform, setting a new price target of $67.00. Historically, NHI's stock has closed lower in 13 out of 18 sessions following previous headlines, with a median move of 2.1% in either direction. This downgrade is a significant event for the real estate investment trust.
Advertisement

National Health Investors (NHI) Q3 Results Raise The Question Of Whether It Is Still Undervalued

https://au.finance.yahoo.com/news/national-health-investors-nhi-q3-111325709.html
National Health Investors (NHI) reported strong Q3 2026 results with US$113.48 million in revenue and a jump in net income, yet its share price has fallen recently. Despite being deemed 18% undervalued by analysts with a fair value of $78.50, the company faces execution risks related to G&A costs and the deployment of proceeds from a US$560 million asset sale. Longer-term, however, NHI has delivered positive shareholder returns over three and five years.

National Health downgraded by BofA Securities with a new price target

https://www.quantisnow.com/insight/national-health-downgraded-by-bofa-securities-with-a-new-price-6789384
BofA Securities has downgraded National Health (NHI) from Buy to Underperform, setting a new price target of $67.00. This action is considered "Very bearish" with a 3/5 rating by Ellis's read, reflecting a less favorable outlook on the real estate investment trust. Historical data shows NHI's stock has closed lower in the majority of sessions following previous headlines.

Huntington Begins Coverage on National Health Investors (NYSE:NHI)

https://www.marketbeat.com/instant-alerts/analyst-huntington-begins-coverage-on-national-health-investors-nyse-nhi-2026-11-11/
Huntington has initiated coverage of National Health Investors (NYSE:NHI) with a "strong-buy" rating. The real estate investment trust currently holds a "Moderate Buy" consensus rating among analysts with an average price target of $81.00. NHI recently reported strong quarterly earnings, significantly beating consensus estimates for both EPS and revenue, although its full-year FFO guidance is slightly below analyst expectations.

National Health Investors Q3 Earnings Call Highlights

https://www.tradingview.com/news/marketbeat:394a90068094b:0-national-health-investors-q3-earnings-call-highlights/
National Health Investors (NHI) revised its full-year distribution guidance downward after its senior housing operating portfolio (SHOP) underperformed in Q3, despite a significant year-over-year NOI growth in its same-store SHOP properties. The company attributed the shortfall to weaker performance outside its core same-store group and higher accelerated spending, though management remains optimistic about long-term growth. NHI is actively recycling capital from skilled nursing into senior housing, with significant investments in SHOP properties and further acquisitions planned for the fourth quarter of 2026.

National Health Investors Q3 2026 Earnings Call Transcript

https://www.benzinga.com/news/26/11/63099544/national-health-investors-q3-2026-earnings-call-transcript
National Health Investors (NHI) reported significant Q3 2026 financial results, including a net income per share of $11.47 driven by the sale of the NHC portfolio. The company is actively repositioning its portfolio, focusing on private pay senior housing (SHOP) and expects 2026 to be a major investment year. Despite some underperformance in non-same-store SHOP properties, NHI maintains a strong financial position and has revised its full-year FFO guidance to $4.68-$4.70 per share, emphasizing disciplined growth and operational improvements.
Advertisement

Earnings call transcript: National Health Investors posts Q3 2026 EPS beat, shares fall By Investing.com

https://uk.investing.com/news/stock-market-news/earnings-call-transcript-national-health-investors-posts-q3-2026-eps-beat-shares-fall-93CH-4972285
National Health Investors (NHI) reported a significant EPS beat in Q3 2026, primarily driven by a large one-time gain from the sale of its NHC portfolio. Despite the headline beat, revenue missed analyst expectations, and normalized FFO declined, causing NHI shares to fall. The company is actively repositioning its portfolio towards senior housing operating properties (SHOP) and expects substantial investment activity in Q4 2026.

National Health Investors Q3 2026 Earnings Call Is Live

https://www.tradingview.com/news/urn:live_audio:quartr.com:729052:0-national-health-investors-q3-2026-earnings-call-is-live/
National Health Investors's quarterly earnings call for Q3 2026 has commenced, where executives will discuss the latest financial results and answer questions from Wall Street analysts. This event is crucial for those following NHI, as management's commentary on future demand, margins, or capital spending can significantly impact market perception. The call offers an opportunity to gain insights beyond the initial earnings release and potentially hear unexpected news.

Senior housing REIT National Health Investors (NHI) issues a Q3 2026 investor presentation.

https://www.stocktitan.net/sec-filings/NHI/8-k-national-health-investors-inc-reports-material-event-4cf58d212a04.html
National Health Investors, Inc. (NHI) furnished an investor presentation titled “Q3 2026 Business Update” and issued a press release on November 9, 2026. NHI, a self-managed real estate investment trust specializing in senior housing and medical facilities, operates through two reportable segments: Real Estate Investments and SHOP. The company emphasized that this information is furnished, not filed for Section 18 purposes.

National Health Investors updates on operations and financial outlook for senior housing and medical real estate.

https://pluang.com/en/news-feed/national-health-investors-nhi-terbitkan-pembaruan-investor-november-2026
National Health Investors, Inc. has provided an investor update focusing on its strategy for owning and managing senior housing and medical real estate properties through its Real Estate Investments and SHOP segments. The update includes forward-looking statements on financial performance and growth opportunities, urging investors to consult SEC filings for detailed risks. This communication aims to keep investors informed about the company's direction in the healthcare real estate sector.

NHI Announces Third Quarter 2026 Results

https://www.tradingview.com/news/prnewswire:1c64e008d39e3:0-nhi-announces-third-quarter-2026-results/
National Health Investors, Inc. (NHI) announced significant financial results for the third quarter ended September 30, 2026, including a diluted EPS of $11.47 compared to $0.69 in the prior year, primarily driven by a $541.6 million gain on the sale of the National Healthcare Corporation leased portfolio. The company reported increased NAREIT FFO per diluted share and substantial investment activity, closing over $395 million in year-to-date investments and anticipating more before year-end, focusing on private-pay senior housing. NHI also declared a $0.94 per share dividend and provided full-year 2026 guidance, reaffirming its commitment to disciplined capital allocation and operational execution.
Advertisement

NHI Issues Investor Update

https://www.tradingview.com/news/prnewswire:b82b96824b132:0-nhi-issues-investor-update/
National Health Investors, Inc. (NHI) has released an investor update available on its investor relations website. The company, a self-managed real estate investment trust established in 1991, focuses on owning, leasing, operating, and financing senior housing communities and medical facilities. This press release includes forward-looking statements and advises investors to review the company's SEC filings for risk factors.

NHI: National Health Investors Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

https://www.quantisnow.com/insight/national-health-investors-inc-filed-sec-form-8-k-regulation-fd-6781489
National Health Investors Inc. (NHI) filed an SEC Form 8-K, furnishing an investor update and a Q3 2026 business update presentation, both dated November 9, 2026. The filing itself contained only a cover page, exhibit index, and signature, with the substantive information in the attached exhibits. The company specified that the furnished material is not deemed filed for Section 18 liability purposes.

Trading the Move, Not the Narrative: (NHI) Edition

https://news.stocktradersdaily.com/news_release/15/Trading_the_Move,_Not_the_Narrative:_NHI_Edition_110226051202_1793657522.html
This article provides an AI-generated analysis of National Health Investors Inc. (NHI), highlighting stable neutral readings in shorter horizons and testing resistance levels. It outlines three institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones, emphasizing risk management and multi-timeframe signal analysis for investors.

National Health Investors (NHI) Expected to Post Earnings on Monday

https://www.marketbeat.com/instant-alerts/upcoming-national-health-investors-nhi-expected-to-post-earnings-on-monday-2026-11-02/
National Health Investors (NHI) is scheduled to release its Q3 2026 earnings after the market closes on Monday, November 9th. Analysts are forecasting earnings of $1.18 per share on $68.53 million in revenue. The company recently declared a quarterly dividend of $0.92 per share, and analysts currently have a "Moderate Buy" consensus rating with an average price target of $81.00.

National Health Investors Inc (NHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

https://www.tradingkey.com/markets/stocks/nhi/technical
This article provides a technical analysis of National Health Investors Inc (NHI), detailing its current support, resistance, technical indicators, and moving averages. It summarizes the signals from various indicators, including MACD, RSI, and different moving averages, to give an overall technical rating. The analysis concludes with FAQs regarding technical ratings, moving averages, and current buy/sell signals for NHI.
Advertisement

National Health Investors, Inc. (NHI) Seasonal Returns Chart - Yahoo Finance

https://ca.finance.yahoo.com/quote/NHI/seasonality/
This article displays the seasonal returns chart for National Health Investors, Inc. (NHI) on Yahoo Finance. It shows the average monthly price return for NHI from 2016 to 2026, with options to view data over different timeframes such as 3Y, 5Y, 10Y, 20Y, and All. The current stock price for NHI is listed at 68.27 USD, up 1.83%.

National Health Investors, Inc. Estimates – NYSE:NHI

https://www.tradingview.com/symbols/NYSE-NHI/financials-estimates/
This article provides an overview of National Health Investors, Inc. (NHI) financial estimates on TradingView. It directs users to explore reported financial data and analyst estimates across income statements, balance sheets, cash flow statements, and valuation metrics, allowing for comparison with average, high, and low estimates. The content emphasizes that it is not investment advice and encourages users to conduct their own research.

National Health Investors (NYSE:NHI) Stock Price

https://simplywall.st/stock/nyse/nhi
National Health Investors (NYSE:NHI) stock is currently undervalued by 14.7% with a fair value of US$78.50, despite a recent 11.03% drop over seven days. Analyst sentiment on the self-managed REIT, which focuses on senior housing and medical facilities, reflects optimism about its senior housing exposure balanced with caution and revised lower price targets. The company is set to report Q3 2026 results on November 9, 2026.

National Health Investors, Inc. (NHI) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_6818_QuantitativeReport_1792540800000
Argus has issued an "Investment Rating" of "HOLD" for National Health Investors Inc (NHI), raising its target price to $63.00, despite the current price being $66.96. The report provides subratings across various categories, including a "Low" rating for Growth. Full details are available in a premium research report.

Wells Fargo Maintains National Health Investors Inc(NHI.US) With Hold Rating, Cuts Target Price to $68

https://www.moomoo.com/news/post/1001576797/wells-fargo-maintains-national-health-investors-inc-nhius-with-hold
Wells Fargo has reiterated its Hold rating for National Health Investors Inc (NHI.US) but has adjusted its target price downwards to $68. This indicates a neutral outlook on the stock, with the price target reduction reflecting potential reevaluation of the company's financial prospects or market conditions.
Advertisement

National Health Investors stock gains 4.42 percent at EUR 59.00

https://www.ad-hoc-news.de/boerse/news/nebenwerte/national-health-investors-stock-gains-4-42-percent-at-eur-59-00/70377180
National Health Investors (NHI) stock rose 4.42 percent to EUR 59.00 on October 20, 2026, compared to the Frankfurt close. The company is set to report its third-quarter results on November 9, 2026, and its stock currently has a market capitalization of USD 3.2 billion with a 5.6 percent dividend yield. Analysts have an average 12-month target of USD 82.25 for NHI, which specializes in healthcare real estate.

National Health Investors, Inc. (NHI) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_6818_QuantitativeReport_1791936000000
National Health Investors Inc. (NHI) currently holds a "HOLD" investment rating from Argus, with a target price of $62.00. The company's industry, management, and safety subratings are all "Medium," while its growth subrating is "Low." Investors can access a full report for more detailed analysis.

National Health Investors stock last at USD 66.28 on October 16, 2026, P/ E 19.2

https://www.ad-hoc-news.de/boerse/news/nebenwerte/national-health-investors-stock-last-at-usd-66-28-on-october-16-2026-p-e-19-2/70351217
National Health Investors (NHI) stock closed at $66.28 on October 16, 2026, marking a 0.93% increase from its previous close, with a P/E ratio of 19.2 and a market capitalization of $3.3 billion. The company reported second-quarter revenue of $121.32 million and is scheduled to release its third-quarter results on November 9, 2026. NHI's stock is currently $2.77 above its 52-week low and $25.10 below its 52-week high, with a trailing dividend yield of 6.00%.

BMO keeps USD 80.00 target for National Health Investors stock

https://www.ad-hoc-news.de/boerse/news/nebenwerte/bmo-keeps-usd-80-00-target-for-national-health-investors-stock/70333050
BMO Capital has reiterated its USD 80.00 price target for National Health Investors (NHI) stock, suggesting a 21.56% upside from its current trading price. This analyst action provides a valuation benchmark ahead of the company's third-quarter results announcement on November 9, 2026. NHI reported strong second-quarter revenue of USD 121.32 million and a net profit of USD 55.67 million, although its stock price remains near its 52-week low.

(NHI) Volatility Zones as Tactical Triggers

https://news.stocktradersdaily.com/news_release/40/NHI_Volatility_Zones_as_Tactical_Triggers_101326075602_1791892562.html
This article analyzes National Health Investors Inc. (NHI) using AI models to identify volatility zones and tactical triggers for trading. It presents three strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis indicating neutral sentiment across all horizons. The analysis highlights a significant risk-reward setup with a potential 9.5% gain versus 0.3% risk.
Advertisement

National Health Investors, Inc. (NHI) Stock Forecasts

https://ca.finance.yahoo.com/research/reports/ARGUS_6818_QuantitativeReport_1791331200000
Argus has issued an investment rating of HOLD for National Health Investors Inc (NHI) and lowered its target price to $62.00 from the current price of $65.28. The report provides subratings across various categories including Industry, Management, Safety, Financial Strength, Growth, and Value, mostly assessing them as "Medium" or "Low". Access to the full report and further premium research requires an upgrade.

NHI6183473 Bond Profile: Coupon and Redemption

https://www.tradingview.com/symbols/FINRA-NHI6183473/profile/
This article provides a detailed profile of the National Health Investors, Inc. 5.35% bond, maturing on February 1, 2033, identified as NHI6183473. It outlines key facts such as the issuer, issue and maturity dates, face value, and minimum denomination. The profile also includes information on interest payments, highlighting a semi-annual fixed rate coupon of 5.35%, and details upcoming coupon payouts and bond redemption.

111,027 National Health Investors, Inc. $NHI Shares Sold by Sound Income Strategies LLC

https://www.marketbeat.com/instant-alerts/filing-111027-national-health-investors-inc-nhi-shares-sold-by-sound-income-strategies-llc-2026-10-09/
Sound Income Strategies LLC reduced its stake in National Health Investors (NYSE: NHI) by 41.1% in the third quarter, selling 111,027 shares but still retaining 159,225 shares valued at $10.3 million. Despite this sale, institutional investors collectively own 62.51% of NHI, and analysts maintain a "Moderate Buy" consensus rating with an average price target of $82.25. The company recently declared a quarterly dividend of $0.92 per share, representing a 5.7% yield, while its shares trade near their 12-month low.

National Health Investors to release Q3 2026 earnings on Nov 9, with a conference call on Nov 10.

https://pluang.com/en/news-feed/nhi-umumkan-rilis-laporan-keuangan-kuartal-tiga-2026
National Health Investors, Inc. will release its Q3 2026 earnings after market close on November 9, 2026, and host a conference call on November 10 at 10:00 a.m. Eastern Time to discuss the results. The company is a REIT focused on senior housing and medical facility investments. A market snapshot for the Real Estate sector as of October 7, 2026, indicated mixed performance among US Real Estate stocks.

NHI stock heads toward November 9 results near a 52-week low

https://www.ad-hoc-news.de/boerse/news/nebenwerte/nhi-stock-heads-toward-november-9-results-near-a-52-week-low/70259907
National Health Investors (NHI) stock is trading near its 52-week low ahead of its third-quarter earnings release on November 9, 2026. Despite a slight revenue increase in Q2, the company's stock price reflects investor scrutiny of its senior-housing strategy. Analysts, however, maintain a "Moderate Buy" consensus with an average price target significantly above the current trading price.
Advertisement

NHI stock hits 52-week low at 64.51 USD

https://www.investing.com/news/company-news/nhi-stock-hits-52week-low-at-6451-usd-93CH-4937225
National Health Investors Inc. (NHI) stock has fallen to a 52-week low of $64.51, representing a 13.94% decline over the past year. Despite the drop, InvestingPro analysis suggests the stock may be undervalued and in oversold territory, offering a 5.74% dividend yield with a 36-year payment history. The company recently surpassed profit expectations in Q2 2026, increased its dividend, and completed a major asset sale, with analysts maintaining price targets suggesting potential upside.

NHI Announces Third Quarter 2026 Earnings Release and Conference Call Dates

https://www.morningstar.com/news/pr-newswire/20261007dc65430/nhi-announces-third-quarter-2026-earnings-release-and-conference-call-dates
National Health Investors, Inc. (NYSE:NHI) will release its third-quarter 2026 earnings after the market closes on Monday, November 9, 2026. A conference call to discuss these results will be held on Tuesday, November 10, 2026, at 10:00 a.m. Eastern Time. Investors can access the call via phone or live webcast, with a replay available online for one year.

Analysts Offer Insights on Real Estate Companies: National Health Investors (NHI) and Digital Realty (DLR)

https://www.theglobeandmail.com/investing/markets/stocks/DLR/pressreleases/4981548/analysts-offer-insights-on-real-estate-companies-national-health-investors-nhi-and-digital-realty-dlr/
Two real estate companies, National Health Investors (NHI) and Digital Realty (DLR), have received bullish ratings from analysts. BMO Capital analysts maintained Buy ratings for both companies, setting price targets of $80.00 for NHI and $225.00 for DLR, with NHI holding a Strong Buy consensus and DLR also having a Strong Buy consensus with a 24.8% upside. Rothschild & Co Redburn also initiated coverage on Digital Realty with a Buy rating.

National Health Investors stock reports USD 107.7 million deal

https://www.ad-hoc-news.de/boerse/news/corporate-news/national-health-investors-stock-reports-usd-107-7-million-deal/70227493
National Health Investors (NHI) acquired six senior housing properties for $107.7 million, expanding its Senior Housing Operating Portfolio (SHOP). The healthcare REIT reported Q2 2026 revenue of $121.32 million and maintained its FY 2026 EPS guidance. Analysts have a "Moderate Buy" consensus with an average 12-month price target of $82.25.

National Health Investors, Inc. (NYSE:NHI) Stock Rated "Moderate Buy" by Wall Street Brokerages

https://www.marketbeat.com/instant-alerts/consensus-national-health-investors-inc-nyse-nhi-stock-rated-moderate-buy-by-wall-street-brokerages-2026-10-03/
National Health Investors (NYSE:NHI) has received a "Moderate Buy" consensus rating from Wall Street brokerages, with five buy ratings and four hold ratings. The average 12-month price target is $82.25, significantly above its current trading price of $65.67. Institutional investors hold 62.51% of NHI's shares, and the company reported strong quarterly results with a declared quarterly dividend of $0.92, offering a 5.6% annualized yield.
Advertisement

Understanding the Setup: (NHI) and Scalable Risk

https://news.stocktradersdaily.com/news_release/23/Understanding_the_Setup:_NHI_and_Scalable_Risk_100326014001_1791006001.html
This article analyzes National Health Investors Inc. (NYSE: NHI) using AI models, identifying a neutral near-term sentiment and elevated downside risk due to a lack of long-term support signals. It provides three institutional trading strategies—Position, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis and support/resistance levels.

National Health Investors acquires six properties for $107.7M By Investing.com

https://www.investing.com/news/company-news/national-health-investors-acquires-six-properties-for-1077m-93CH-4927066
National Health Investors, Inc. has acquired six senior housing properties totaling 443 units across Kentucky, Michigan, and Tennessee for $107.7 million, with an additional $2.3 million investment planned. These properties will be managed by Allegro Living Management and are expected to yield an initial net operating income of approximately 7.0%. The company is also evaluating a pipeline of potential investments worth about $285 million.

Zacks upgrades National Health Investors stock to Hold

https://www.ad-hoc-news.de/boerse/news/nebenwerte/zacks-upgrades-national-health-investors-stock-to-hold/70210603
Zacks Research upgraded National Health Investors (NHI) from a strong sell to a hold rating. This change comes after NHI reported adjusted second-quarter earnings of $1.15 per share, surpassing the expected $0.87, and raised its quarterly dividend to $0.94 per share. Despite revenue slightly missing expectations, the company saw significant growth in senior housing operating portfolio net operating income and maintained its net debt to adjusted EBITDA ratio within target.

National Health Investors acquires six properties for $107.7M By Investing.com

https://ng.investing.com/news/stock-market-news/national-health-investors-acquires-six-properties-for-1077m-93CH-2717715
National Health Investors Inc. (NYSE:NHI) has acquired six senior housing properties for $107.7 million across Kentucky, Michigan, and Tennessee. These properties, totaling 443 units, will be managed by Allegro Living Management and are expected to yield an initial net operating income of approximately 7.0%. NHI also has additional investment opportunities under Letters of Intent and purchase options, with a further pipeline of potential investments totaling $285 million.

A 443-unit senior-housing deal covers 3 states.

https://www.stocktitan.net/news/NHI/nhi-announces-107-7-million-shop-iq3mhky5fpr2.html
National Health Investors (NHI) has invested $107.7 million, including transaction costs, to acquire six senior housing properties with 443 units across Kentucky, Michigan, and Tennessee. These properties will be part of NHI's Senior Housing Operating Portfolio (SHOP) and managed by Allegro Living Management. NHI anticipates an initial net operating income yield of approximately 7.0%, or 6.6% after routine capital expenditures, from these acquisitions.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement